Ataraxis AI, a frontier laboratory developing artificial intelligence (AI)–powered prognostic tools for oncology, and MEDSIR ...

Sanofi (($SNYNF)) announced an update on their ongoing clinical study. Sanofi, in collaboration with Teva Branded Pharmaceutical Products R&D LLC, ...

Direct mailing human papillomavirus (HPV) self-testing kits to women's homes was cost-effective for those who regularly ...

VIENNA — Tirzepatide was associated with improvements in body weight and body composition, and with lower insulin doses, in the first-ever randomized controlled trial (RCT) of the drug in people with ...

Symptomatic or viral rebound is estimated to occur in 0.8% to 32% of Paxlovid recipients and 1.1% to 31% of those who receive ...

The Company will present the reported topline results from its phase 3 SHIELD II trial at one of the world’s leading surgical ...

Sanofi (($SNYNF)) announced an update on their ongoing clinical study. Sanofi, in collaboration with Teva Branded Pharmaceutical Products R&D LLC, ...

Parents improved their use of appropriate child car seats after remote motivational counseling and mobile-based support, ...

Overall Survival Analysis of the Phase III CodeBreaK 300 Study of Sotorasib Plus Panitumumab Versus Investigator's Choice in Chemorefractory KRAS G12C Colorectal Cancer This randomized phase Ib ...

BMJ Group announced its retraction of an analysis indicating that small daily amounts of apple cider vinegar may help produce ...